Browsing Tag
Desidustat
2 posts
Zydus Lifesciences (NSE: ZYDUSLIFE) wins NMPA approval for Desidustat in China, unlocking access to 120 million CKD patients
Zydus Lifesciences' novel oral drug Desidustat receives China NMPA approval for CKD anaemia, unlocking a market of 120 million patients. Read the strategic analysis.
Zydus Lifesciences, Sun Pharma to co-market Desidustat for CKD patients in India
Zydus Lifesciences Limited and Sun Pharmaceutical Industries Limited have announced a licensing agreement for the co-marketing of Desidustat,…